NCT00794768View on ClinicalTrials.gov

Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

desloratadine 5 mg

Clarinex 5 mg daily x 7 days

DRUG

fexofenadine

Allegra 180 mg daily x 7 days

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00794768 - Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178) | Biotech Hunter | Biotech Hunter